Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Anne Kessinger
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Anatomy
Disorders
Concepts & Ideas
Chemicals & Drugs
Sign-in to see full Profile
Network (preview)
63
Armitage, James
47
Bierman, Philip
42
Vose, Julie
25
Bishop, Michael
25
Sharp, Graham
24
Tarantolo, Stefano
21
Haire, William
20
Weisenburger, Dennis
19
Jackson, John
15
Reed, Elizabeth
14
Joshi, Shantaram
14
Warkentin, Phyllis
11
Pavletic, Steven
10
Anderson, James
9
Pirruccello, Samuel
Sign-in to see all Coauthors
Publications
- Clark Orlo H; Benson Al B; Berlin Jordan D; Choti Michael A; Doherty Gerard M; Engstrom Paul F; Gibbs John F; Heslin Martin J; Kessinger Anne; Kulke Matthew H; Kvols Larry; Salem Riad; Saltz Leonard; Shah Manisha H; Shibata Stephen; Strosberg Jonathan R; Yao James C;
NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.
- Motzer Robert J; Agarwal Neeraj; Beard Clair; Bolger Graeme B; Boston Barry; Carducci Michael A; Choueiri Toni K; Figlin Robert A; Fishman Mayer; Hancock Steven L; Hudes Gary R; Jonasch Eric; Kessinger Anne; Kuzel Timothy M; Lange Paul H; Levine Ellis G; Margolin Kim A; Michaelson M Dror; Olencki Thomas; Pili Roberto; Redman Bruce G; Robertson Cary N; Schwartz Lawrence H; Sheinfeld Joel; Wang Jue
NCCN clinical practice guidelines in oncology: kidney cancer.
- Motzer Robert J; Agarwal Neeraj; Beard Clair; Bolger Graeme B; Boston Barry; Carducci Michael A; Choueiri Toni K; Figlin Robert A; Fishman Mayer; Hancock Steven L; Hudes Gary R; Jonasch Eric; Kessinger Anne; Kuzel Timothy M; Lange Paul H; Levine Ellis G; Margolin Kim A; Michaelson M Dror; Olencki Thomas; Pili Roberto; Redman Bruce G; Robertson Cary N; Schwartz Lawrence H; Sheinfeld Joel; Wang Jue
NCCN clinical practice guidelines in oncology: testicular cancer.
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Anne Kessinger (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Clark Orlo H; Benson Al B; Berlin Jordan D; Choti Michael A; Doherty Gerard M; Engstrom Paul F; Gibbs John F; Heslin Martin J; Kessinger Anne; Kulke Matthew H; Kvols Larry; Salem Riad; Saltz Leonard; Shah Manisha H; Shibata Stephen; Strosberg Jonathan R; Yao James C;
NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(7):712-47.
-
2009: Motzer Robert J; Agarwal Neeraj; Beard Clair; Bolger Graeme B; Boston Barry; Carducci Michael A; Choueiri Toni K; Figlin Robert A; Fishman Mayer; Hancock Steven L; Hudes Gary R; Jonasch Eric; Kessinger Anne; Kuzel Timothy M; Lange Paul H; Levine Ellis G; Margolin Kim A; Michaelson M Dror; Olencki Thomas; Pili Roberto; Redman Bruce G; Robertson Cary N; Schwartz Lawrence H; Sheinfeld Joel; Wang Jue
NCCN clinical practice guidelines in oncology: kidney cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(6):618-30.
-
2009: Motzer Robert J; Agarwal Neeraj; Beard Clair; Bolger Graeme B; Boston Barry; Carducci Michael A; Choueiri Toni K; Figlin Robert A; Fishman Mayer; Hancock Steven L; Hudes Gary R; Jonasch Eric; Kessinger Anne; Kuzel Timothy M; Lange Paul H; Levine Ellis G; Margolin Kim A; Michaelson M Dror; Olencki Thomas; Pili Roberto; Redman Bruce G; Robertson Cary N; Schwartz Lawrence H; Sheinfeld Joel; Wang Jue
NCCN clinical practice guidelines in oncology: testicular cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(6):672-93.
-
2009: Avery Eric J; Kessinger Anne; Ganti Apar Kishor
Therapeutic options for elderly patients with advanced non-small cell lung cancer.
Cancer treatment reviews 2009;35(4):340-4.
-
2009: Miller Stanley J; Alam Murad; Andersen James; Berg Daniel; Bichakjian Christopher K; Bowen Glen; Cheney Richard T; Glass L Frank; Grekin Roy C; Hallahan Dennis E; Kessinger Anne; Lee Nancy Y; Liegeois Nanette; Lydiatt Daniel D; Michalski Jeff; Morrison William H; Nehal Kishwer S; Nelson Kelly C; Nghiem Paul; Olencki Thomas; Oseroff Allan R; Perlis Clifford S; Rosenberg E William; Shaha Ashok R; Urist Marshall M; Wang Linda C;
Merkel cell carcinoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(3):322-32.
-
2008: Dawson Nancy A; Halabi Susan; Ou San-San; Biggs David D; Kessinger Anne; Vogelzang Nicholas; Clamon Gerald H; Nanus David M; Kelly W Kevin; Small Eric J;
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004.
Clinical genitourinary cancer 2008;6(2):110-6.
-
2008: Kalemkerian Gregory P; Akerley Wallace; Downey Robert J; Ettinger David S; Fossella Frank; Grecula John C; Jahan Thierry; Johnson Bruce E; Kessinger Anne; Koczywas Marianna; Langer Corey J; Martins Renato; Niell Harvey B; Pan Charles C; Ramnath Nithya; Ready Neal; Robert Francisco; Williams Charles C
Small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(3):294-314.
-
2008: Ettinger David S; Akerley Wallace; Bepler Gerold; Chang Andrew; Cheney Richard T; Chirieac Lucian R; D'Amico Thomas A; Demmy Todd L; Feigenberg Steven J; Figlin Robert A; Govindan Ramaswamy; Grannis Frederic W; Jahan Thierry; Jahanzeb Mohammad; Kessinger Anne; Komaki Ritsuko; Kris Mark G; Langer Corey J; Le Quynh-Thu; Martins Renato; Otterson Gregory A; Patel Jyoti D; Robert Francisco; Sugarbaker David J; Wood Douglas E
Non-small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(3):228-69.
-
2007: Miller Stanley J; Alam Murad; Andersen James; Berg Daniel; Bichakjian Christopher K; Bowen Glen; Cheney Richard T; Glass Frank; Grekin Roy C; Grichnik James M; Kessinger Anne; Lee Nancy Y; Lessin Stuart; Lydiatt Daniel D; Margolis Lawrence W; Michalski Jeffrey; Nehal Kishwer S; Nghiem Paul; Oseroff Allan R; Rosenberg E William; Shaha Ashok R; Siegle Ronald J; Urist Marshall M;
Dermatofibrosarcoma protuberans.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(5):550-5.
-
2007: Miller Stanley J; Alam Murad; Andersen James; Berg Daniel; Bichakjian Christopher K; Bowen Glen; Cheney Richard T; Glass Frank; Grekin Roy C; Grichnik James M; Kessinger Anne; Lee Nancy Y; Lessin Stuart; Lydiatt Daniel D; Margolis Lawrence W; Michalski Jeffrey; Nehal Kishwer S; Nghiem Paul; Oseroff Allan R; Rosenberg E William; Shaha Ashok R; Siegle Ronald J; Urist Marshall M;
Basal cell and squamous cell skin cancers.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(5):506-29.
-
2007: Ganti Apar Kishor; Zhen Weining; Kessinger Anne
Limited-stage small-cell lung cancer: therapeutic options.
Oncology (Williston Park, N.Y.) 2007;21(3):303-12; discussion 312, 315-8, 323.
-
2006: Miller Stanley J; Alam Murad; Andersen James; Berg Daniel; Bichakjian Christopher K; Bowen Glen; Cheney Richard T; Glass Frank; Grekin Roy C; Grichnik James M; Johnson Timothy M; Kessinger Anne; Lee Nancy Y; Lessin Stuart; Lydiatt Daniel D; Margolis Lawrence W; Nehal Kishwer S; Nghiem Paul; Oseroff Allan R; Rosenberg E William; Shaha Ashok R; Siegle Ronald J;
Merkel cell carcinoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(7):704-12.
-
2006: Ganti Apar Kishor; Landmark James D; Kessinger Anne; Smith Lynette M; Tarantolo Stefano R
Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.
In vivo (Athens, Greece) 2006;20(4):559-63.
-
2006: Johnson Bruce E; Crawford Jeffrey; Downey Robert J; Ettinger David S; Fossella Frank; Grecula John C; Jahan Thierry; Kalemkerian Gregory P; Kessinger Anne; Koczywas Marianna; Langer Corey J; Martins Renato; Marymont Maryanne Hoffman; Niell Harvey B; Ramnath Nithya; Robert Francisco; Williams Charles C;
Small cell lung cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(6):602-22.
-
2006: Ettinger David S; Bepler Gerold; Bueno Raphael; Chang Andrew; Chang Joe Y; Chirieac Lucian R; D'Amico Thomas A; Demmy Todd L; Feigenberg Steven J; Grannis Frederic W; Jahan Thierry; Jahanzeb Mohammad; Kessinger Anne; Komaki Ritsuko; Kris Mark G; Langer Corey J; Le Quynh-Thu; Martins Renato; Otterson Gregory A; Robert Francisco; Sugarbaker David J; Wood Douglas E;
Non-small cell lung cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(6):548-82.
-
2006: Clark Orlo H; Ajani Jaffer; Benson Al B; Byrd David; Doherty Gerard M; Engstrom Paul F; Ettinger David S; Gibbs John F; Heslin Martin J; Kandeel Fouad; Kessinger Anne; Kulke Matthew H; Kvols Larry; Nemcek Albert A; Olson John A; Ratliff Thomas W; Saltz Leonard; Schteingart David E; Shah Manisha H; Shibata Stephen;
Neuroendocrine tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(2):102-38.
-
2005: Sharp J Graham; Murphy Barbara O'Kane; Jackson John D; Brusnahan Susan K; Kessinger Anne; Neff James R
Promises and pitfalls of stem cell therapy for promotion of bone healing.
Clinical orthopaedics and related research 2005;(435):52-61.
-
2005: Pavletic Steven Z; Smith Lynette M; Bishop Michael R; Lynch James C; Tarantolo Stefano R; Vose Julie M; Bierman Philip J; Hadi Abdul; Armitage James O; Kessinger Anne
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
American journal of hematology 2005;78(4):265-74.
-
2005: Kessinger A; O'Kane Murphy B; Jackson J D; Sharp J G
An ex vivo model of hematopoietic stem cell mobilization.
Cytotherapy 2005;7(6):463-9.
-
2004: Thompson Austin B; Kessinger Anne; Sharp J Graham
A pilot evaluation of micrometastases for the prediction of outcome in lung cancer.
Chest 2004;125(5 Suppl):156S-7S.
-
2003: Reed E; Kessinger A; Murphy B; Tarantolo S; Traystman M; Sharp J Graham
Occult tumor cells detected in autologous blood stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4-9 positive nodes treated with adjuvant high-dose therapy and stem cell transplantation.
Bone marrow transplantation 2003;31(7):571-4.
-
2003: Kessinger A; Sharp J G
The whys and hows of hematopoietic progenitor and stem cell mobilization.
Bone marrow transplantation 2003;31(5):319-29.
-
2003: Joshi S S; Bishop M R; Lynch J C; Tarantolo S R; Abhyankar S; Bierman P J; Vose J M; Geller R B; McGuirk J; Foran J; Bociek R G; Hadi A; Day S D; Armitage J O; Kessinger A; Pavletic Z S
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
Cytotherapy 2003;5(6):542-52.
-
2003: Gordon B G; Kessinger A; Mann S L; Prentice E D
The impact of escalating regulatory requirements on the conduct of clinical research.
Cytotherapy 2003;5(4):309-13.
-
2002: Bierman P J; Lynch J C; Bociek R G; Whalen V L; Kessinger A; Vose J M; Armitage J O
The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1370-7.
-
2002: Vose Julie M; Sharp Graham; Chan Wing C; Nichols Craig; Loh Kevin; Inwards David; Rifkin Robert; Bierman Philip J; Lynch James C; Weisenburger Dennis D; Kessinger Anne; Armitage James O
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2344-52.
-
2002: Pusic I; Pavletic S Z; Kessinger A; Tarantolo S R; Bishop M R
Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host disease.
Bone marrow transplantation 2002;29(8):709-10.
-
2002: Murphy Barbara O'Kane; Joshi Shantaram; Kessinger Anne; Reed Elizabeth; Sharp J Graham
A murine model of bone marrow micrometastasis in breast cancer.
Clinical & experimental metastasis 2002;19(7):561-9.
-
2002: Sharp J G; McGuire T R; Mann S L; Murphy B; Kessinger A
Plasma from poorly mobilizing human subjects inhibits cytokine-induced murine blood stem-cell mobilization.
Cytotherapy 2002;4(4):365-73.
-
2002: Demirkazik Ahmet; Kessinger Anne; Lynch James; Reed Elizabeth; Tarantolo Stefano; Sharp J Graham
Effect of prior therapy and bone marrow metastases on progenitor cell content of blood stem cell harvests in breast cancer patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(5):268-72.
-
2001: Pavletic S Z; Odell J R; Pirruccello S J; Ursick M M; Haire C E; Sharp J G; Kessinger A; Klassen L W
Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience.
The Journal of rheumatology. Supplement 2001;64():13-20.
-
2001: Joshi S S; Lynch J C; Pavletic S Z; Tarantolo S R; Pirruccello S J; Kessinger A; Bishop M R
Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics.
Blood 2001;98(6):1963-70.
-
2001: Demirkazik A; Kessinger A; Armitage J O; Bierman P J; Lynch J; Vose J; Chan W; Sharp J G
Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation.
Bone marrow transplantation 2001;28(2):207-12.
-
2001: Kessinger A; Mann S; Murphy B O; Jackson J D; Sharp J G
Circulating factors may be responsible for murine strain-specific responses to mobilizing cytokines.
Experimental hematology 2001;29(6):775-8.
-
2001: McGuire T R; Kessinger A; Hock L; Sharp J G
Elevated transforming growth factor beta levels in the plasma of cytokine-treated cancer patients and normal allogeneic stem cell donors.
Cytotherapy 2001;3(5):361-4.
-
2000: Sharp J G; Kessinger A; Lynch J C; Pavletic Z S; Joshi S S
Blood stem cell transplantation: factors influencing cellular immunological reconstitution.
Journal of hematotherapy & stem cell research 2000;9(6):971-81.
-
2000: Joshi S S; Tarantolo S R; Kuszynski C A; Kessinger A
Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4351-8.
-
2000: Bishop M R; Tarantolo S R; Geller R B; Lynch J C; Bierman P J; Pavletic Z S; Vose J M; Kruse S; Dix S P; Morris M E; Armitage J O; Kessinger A
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation.
Blood 2000;96(1):80-5.
-
2000: Bishop M R; Tarantolo S R; Pavletic Z S; Lynch J C; Morris M E; Zacharias D; Armitage J O; Kessinger A
Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(11):2269-72.
-
2000: Pavletic Z S; Arrowsmith E R; Bierman P J; Goodman S A; Vose J M; Tarantolo S R; Stein R S; Bociek G; Greer J P; Wu C D; Kollath J P; Weisenburger D D; Kessinger A; Wolff S N; Armitage J O; Bishop M R
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
Bone marrow transplantation 2000;25(7):717-22.
-
2000: Gordon B; Lyden E; Lynch J; Tarantolo S; Pavletic Z S; Bishop M; Reed E; Kessinger A; Haire W
Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients.
Bone marrow transplantation 2000;25(1):79-83.
-
2000: Joshi S S; Miller K; Jackson J D; Warkentin P; Kessinger A
Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients.
Cytotherapy 2000;2(1):15-24.
-
1999: Freeman M; Vose J; Bennett C; Anderson J; Kessinger A; Turner K; Pierson J; Bishop M; Bierman P; Armitage J
Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995.
Bone marrow transplantation 1999;24(6):679-84.
-
1999: Tezcan H; Vose J M; Bast M; Bierman P J; Kessinger A; Armitage J O
Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
Leukemia & lymphoma 1999;34(3-4):273-85.
-
1999: Kessinger A
Collection of autologous peripheral blood stem cells in steady state.
Baillière's best practice & research. Clinical haematology 1999;12(1-2):19-26.
-
1998: Gordon B; Tarantolo S; Ruby E; Stephens L; Lynch J; Kessinger A; Haire W
Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation.
Bone marrow transplantation 1998;22(10):999-1003.
-
1998: Joshi S S; Babushkina-Patz N N; Verbik D J; Gross T G; Tarantolo S R; Kuszynski C A; Pirruccello S J; Bishop M R; Kessinger A
Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells.
International journal of oncology 1998;13(4):791-9.
-
1998: Pavletic Z S; Bierman P J; Vose J M; Bishop M R; Wu C D; Pierson J L; Kollath J P; Weisenburger D D; Kessinger A; Armitage J O
High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):1023-6.
-
1998: Sharp J G; Kessinger A; Clausen S R; Mann S L; O'Kane-Murphy B
Concurrent partial body radiation prevents cytokine mobilization of blood progenitor cells: an effect mediated by a circulating factor.
Journal of hematotherapy 1998;7(4):343-9.
-
1998: Vose J M; Bierman P J; Lynch J C; Weisenburger D D; Kessinger A; Chan W C; Greiner T C; Armitage J O
Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):844-9.
-
1998: Pavletic Z S; Joshi S S; Pirruccello S J; Tarantolo S R; Kollath J; Reed E C; Bierman P J; Vose J M; Warkentin P I; Gross T G; Nasrati K; Armitage J O; Kessinger A; Bishop M R
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies.
Bone marrow transplantation 1998;21(1):33-41.
-
1998: Watanabe T; Dave B; Heimann D G; Jackson J D; Kessinger A; Talmadge J E
Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation.
Experimental hematology 1998;26(1):10-8.
-
1998: Kessinger A; Sharp J G
Mobilization of blood stem cells.
Stem cells (Dayton, Ohio) 1998;16 Suppl 1():139-43.
-
1998: Haire W D; Ruby E I; Stephens L C; Reed E; Tarantolo S R; Pavletic Z S; Bierman P J; Bishop M; Kessinger A; Vose J; Armitage J O
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(3):142-50.
-
1998: Kessinger A
Consensus conference on high-dose therapy with hematopoietic stem cell transplantation in diffuse large-cell lymphoma. Type of cells, optimal mobilization of stem cells--positive and negative selection.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 1():S23-30.
-
1997: Bishop M R; Jackson J D; Tarantolo S R; O'Kane-Murphy B; Iversen P L; Bayever E; Joshi S M; Sharp J G; Pierson J L; Warkentin P I; Armitage J O; Kessinger A
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome.
Journal of hematotherapy 1997;6(5):441-6.
-
1997: Stephens L C; Haire W D; Tarantolo S; Reed E; Schmit-Pokorny K; Kessinger A; Klein R
Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC).
Transfusion science 1997;18(2):187-93.
-
1997: Mann S L; Joshi S S; Crouse D A; Armitage J O; Kessinger A; Weisenburger D D; Vaughan W P; Sharp J G
Increased hematopoietic progenitor cell maintenance in long-term bone marrow cultures containing minimal numbers of contaminating breast cancer cells.
Breast cancer research and treatment 1997;44(2):115-21.
-
1997: Watanabe T; Dave B; Heimann D G; Lethaby E; Kessinger A; Talmadge J E
GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression.
Bone marrow transplantation 1997;19(12):1175-81.
-
1997: Pavletic Z S; Bishop M R; Tarantolo S R; Martin-Algarra S; Bierman P J; Vose J M; Reed E C; Gross T G; Kollath J; Nasrati K; Jackson J D; Armitage J O; Kessinger A
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1608-16.
-
1997: Bishop M R; Tarantolo S R; Jackson J D; Anderson J R; Schmit-Pokorny K; Zacharias D; Pavletic Z S; Pirruccello S J; Vose J M; Bierman P J; Warkentin P I; Armitage J O; Kessinger A
Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1601-7.
-
1997: Gordon B; Haire W; Ruby E; Kotulak G; Stephens L; Kessinger A; Armitage J
Factors predicting morbidity following hematopoietic stem cell transplantation.
Bone marrow transplantation 1997;19(5):497-501.
-
1997: Bierman P J; Vose J M; Anderson J R; Bishop M R; Kessinger A; Armitage J O
High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):445-50.
-
1997: Talmadge J E; Reed E; Ino K; Kessinger A; Kuszynski C; Heimann D; Varney M; Jackson J; Vose J M; Bierman P J
Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
Bone marrow transplantation 1997;19(2):161-72.
-
1996: Bishop M R; Jackson J D; O'Kane-Murphy B; Schmit-Pokorny K; Vose J M; Bierman P J; Warkentin P I; Armitage J O; Garrison L; Kessinger A
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2521-6.
-
1996: Vose J M; Bierman P J; Anderson J R; Harrison K A; Dalrymple G V; Byar K; Kessinger A; Armitage J O
Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2473-9.
-
1996: Mills K C; Gross T G; Varney M L; Heimann D G; Reed E C; Kessinger A; Talmadge J E
Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
Bone marrow transplantation 1996;18(1):53-61.
-
1996: Vose J M; Bierman P J; Ruby E; Reed E C; Bishop M R; Tarantolo S; Kessinger A; Armitage J O
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Bone marrow transplantation 1996;17(6):951-6.
-
1996: Verbik D J; Stinson W W; Brunda M J; Kessinger A; Joshi S S
In vivo therapeutic effects of interleukin-12 against highly metastatic residual lymphoma.
Clinical & experimental metastasis 1996;14(3):219-29.
-
1996: Watanabe T; Brown G S; Kelsey L S; Yan Y; Jackson J D; Ewel C; Kessinger A; Talmadge J E
In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation.
Experimental hematology 1996;24(6):713-21.
-
1996: Bishop M R; Iversen P L; Bayever E; Sharp J G; Greiner T C; Copple B L; Ruddon R; Zon G; Spinolo J; Arneson M; Armitage J O; Kessinger A
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1320-6.
-
1996: Gordon B; Haire W; Ruby E; Stephens L; Kotulak G; Kessinger A
Prolonged deficiency of protein C following hematopoietic stem cell transplantation.
Bone marrow transplantation 1996;17(3):415-9.
-
1996: Bierman P J; Anderson J R; Freeman M B; Vose J M; Kessinger A; Bishop M R; Armitage J O
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(2):151-6.
-
1996: Talmadge J E; Reed E C; Kessinger A; Kuszynski C A; Perry G A; Gordy C L; Mills K C; Thomas M L; Pirruccello S J; Letheby B A; Arneson M A; Jackson J D
Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation.
Bone marrow transplantation 1996;17(1):101-9.
-
1996: Sharp J G; Kessinger A; Mann S; Crouse D A; Armitage J O; Bierman P; Weisenburger D D
Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):214-9.
-
1995: Wu A G; Joshi S S; Chan W C; Iversen P L; Jackson J D; Kessinger A; Pirruccello S J; Sanger W G; Sharp J G; Verbik D J
Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
Leukemia & lymphoma 1995;20(1-2):67-76.
-
1995: Kessinger A
The Nebraska experience.
Stem cells (Dayton, Ohio) 1995;13 Suppl 3():23-7.
-
1995: Sharp J G; Bishop M; Chan W C; Greiner T; Joshi S S; Kessinger A; Reed E; Sanger W; Tarantolo S; Traystman M
Detection of minimal residual disease in hematopoietic tissues.
Annals of the New York Academy of Sciences 1995;770():242-61.
-
1995: Martin-Algarra S; Bishop M R; Tarantolo S; Cowles M K; Reed E; Anderson J R; Vose J M; Bierman P; Armitage J O; Kessinger A
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Experimental hematology 1995;23(14):1503-8.
-
1995: Haire W D; Ruby E I; Gordon B G; Patil K D; Stephens L C; Kotulak G D; Reed E C; Vose J M; Bierman P J; Kessinger A
Multiple organ dysfunction syndrome in bone marrow transplantation.
JAMA : the journal of the American Medical Association 1995;274(16):1289-95.
-
1995: Kessinger A; Bishop M R; Jackson J D; O'Kane-Murphy B; Vose J M; Bierman P J; Reed E C; Warkentin P I; Armitage J O; Sharp J G
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies.
Experimental hematology 1995;23(7):609-12.
-
1995: Kessinger A
Do autologous peripheral blood cell transplants provide more than hematopoietic recovery?
Stem cells (Dayton, Ohio) 1995;13(4):351-4.
-
1995: Verbik D J; Jackson J D; Pirruccello S J; Patil K D; Kessinger A; Joshi S S
Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections.
Blood 1995;85(7):1964-70.
-
1995: Kessinger A; Bishop M R; Anderson J R; Armitage J O; Bierman P J; Reed E C; Tarantolo S; Tempero M A; Vose J M; Warkentin P I
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization.
Journal of hematotherapy 1995;4(2):81-4.
-
1995: Haire W D; Stephens L C; Kotulak G D; Schmit-Pokorny K; Kessinger A
Double-lumen inferior vena cava catheters for peripheral stem cell apheresis and transplantations.
Transfusion science 1995;16(1):79-84.
-
1995: Stewart D A; Vose J M; Weisenburger D D; Anderson J R; Ruby E I; Bast M A; Bierman P J; Kessinger A; Armitage J O
The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(3):263-6.
-
1994: Vaughan W P; Reed E C; Edwards B; Kessinger A
High-dose cyclophosphamide, thiotepa and hydroxyurea with autologous hematopoietic stem cell rescue: an effective consolidation chemotherapy regimen for early metastatic breast cancer.
Bone marrow transplantation 1994;13(5):619-24.
-
1994: Bishop M R; Anderson J R; Jackson J D; Bierman P J; Reed E C; Vose J M; Armitage J O; Warkentin P I; Kessinger A
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft.
Blood 1994;83(2):610-6.
-
1994: Kessinger A; Armitage J; Bierman P; Bishop M; Joshi S; Reed E; Sharp G; Talmadge J; Vose J
Clinical outcome of peripheral blood stem cell support.
Medical oncology (Northwood, London, England) 1994;11(2):43-6.
-
1994: Warkentin P I; Jackson J D; Letheby B; Kessinger A
Effective cryopreservation of cytokine-mobilized autologous peripheral blood stem cells using non-controlled rate freezing.
Progress in clinical and biological research 1994;389():643-7.
-
1994: Bishop M R; Warkentin P I; Jackson J D; Bayever E; Iversen P L; Whalen V I; Lastovica J; Haines K; Kessinger A
Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.
Progress in clinical and biological research 1994;389():183-7.
-
1994: Jackson J D; Letheby B; O'Kane Murphy B; Costas P; Wang P N; Bishop M R; Kessinger A; Warkentin P I
Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cells.
Progress in clinical and biological research 1994;389():471-7.
-
1994: O'Kane-Murphy B; Jackson J D; Kuszynski C; Costas P; Wang P N; Warkentin P I; Kessinger A
CD34 analysis in erythropoietin mobilized peripheral blood stem cells.
Progress in clinical and biological research 1994;389():371-6.
-
1993: Bierman P J; Bagin R G; Jagannath S; Vose J M; Spitzer G; Kessinger A; Dicke K A; Armitage J O
High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):767-73.
-
1993: Vose J M; Anderson J R; Kessinger A; Bierman P J; Coccia P; Reed E C; Gordon B; Armitage J O
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1846-51.
-
1993: Vose J M; Armitage J O; Kessinger A
High-dose chemotherapy and autologous transplant with peripheral-blood stem cells.
Oncology (Williston Park, N.Y.) 1993;7(8):23-9; discussion 29-30, 33-4.
-
1993: Vose J M; Reed E C; Pippert G C; Anderson J R; Bierman P J; Kessinger A; Spinolo J; Armitage J O
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1306-10.
-
1993: Kessinger A
Is blood or bone marrow better?
Stem cells (Dayton, Ohio) 1993;11(4):290-5.
-
1993: Gordon B G; Haire W D; Stephens L C; Kotulak G D; Kessinger A
Protein C deficiency following hematopoietic stem cell transplantation: optimization of intravenous vitamin K dose.
Bone marrow transplantation 1993;12(1):73-6.
-
1993: Kessinger A
Utilization of peripheral blood stem cells in autotransplantation.
Hematology/oncology clinics of North America 1993;7(3):535-45.
-
1993: Iwen P C; Reed E C; Armitage J O; Bierman P J; Kessinger A; Vose J M; Arneson M A; Winfield B A; Woods G L
Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1993;14(3):131-9.
-
1993: Stephens L C; Haire W D; Schmit-Pokorny K; Kessinger A; Kotulak G
Granulocyte macrophage colony stimulating factor: high incidence of apheresis catheter thrombosis during peripheral stem cell collection.
Bone marrow transplantation 1993;11(1):51-4.
-
1993: Bayever E; Iversen P L; Bishop M R; Sharp J G; Tewary H K; Arneson M A; Pirruccello S J; Ruddon R W; Kessinger A; Zon G
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial.
Antisense research and development 1993;3(4):383-90.
-
1993: Kessinger A; Vose J M; Bierman P J; Bishop M; Armitage J O
Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients.
Journal of hematotherapy 1993;2(3):361-2.
-
1993: Kessinger A
Peripheral stem cell transplantation at a single institution.
Journal of hematotherapy 1993;2(4):519-20.
-
1992: Vose J M; Bierman P J; Anderson J R; Kessinger A; Pierson J; Nelson J; Frappier B; Schmit-Pokorny K; Weisenburger D D; Armitage J O
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up.
Blood 1992;80(8):2142-8.
-
1992: Inwards D; Kessinger A
Peripheral blood stem cell transplantation: historical perspective, current status, and prospects for the future.
Transfusion medicine reviews 1992;6(3):183-90.
-
1992: Vaughan W P; Bierman P J; Reed E C; Glenn L D; Kessinger A; Armitage J O
High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agent.
Seminars in oncology 1992;19(3 Suppl 9):110-5.
-
1992: Sharp J G; Joshi S S; Armitage J O; Bierman P; Coccia P F; Harrington D S; Kessinger A; Crouse D A; Mann S L; Weisenburger D D
Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique.
Blood 1992;79(4):1074-80.
-
1992: Vose J M; Kennedy B C; Bierman P J; Kessinger A; Armitage J O
Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies.
Cancer 1992;69(3):784-9.
-
1992: Kessinger A
Autologous and allogeneic transplantation with peripheral blood stem cells.
Progress in clinical and biological research 1992;377():603-10; discussion 611-3.
-
1992: Jackson J; Kloster T; Welniak L; Damon M; Rehder B; Schmechel B; Ward B; Kessinger A
Peripheral blood-derived stem cells can be successfully cryopreserved without using controlled-rate freezing.
Progress in clinical and biological research 1992;377():367-71.
-
1992: Letheby B; Jackson J; Greally J; Warkentin P; Smith D; Vose J; Bierman P; Kessinger A; Coccia P; Armitage J
Comparison of two methods of bone marrow processing for autologous bone marrow transplantation.
Progress in clinical and biological research 1992;377():345-51.
-
1991: Gordon B; Haire W; Kessinger A; Duggan M; Armitage J
High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma.
Bone marrow transplantation 1991;8(6):497-502.
-
1991: Armitage J O; Bierman P J; Vose J M; Anderson J R; Weisenburger D D; Kessinger A; Reed E C; Vaughan W P; Coccia P F; Purtilo D T
Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.
The American journal of medicine 1991;91(6):605-11.
-
1991: Lobo F; Kessinger A; Landmark J D; Smith D M; Weisenburger D D; Wigton R S; Armitage J O
Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy.
Bone marrow transplantation 1991;8(5):389-92.
-
1991: Kessinger A; Vose J M; Bierman P J; Armitage J O
High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.
Experimental hematology 1991;19(10):1013-6.
-
1991: Conlan M G; Haire W D; Kessinger A; Armitage J O
Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation.
Bone marrow transplantation 1991;7(6):475-9.
-
1991: Kessinger A; Bierman P J; Vose J M; Armitage J O
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease.
Blood 1991;77(11):2322-5.
-
1991: Haire W D; Lieberman R P; Lund G B; Kessinger A
Translumbar inferior vena cava catheters.
Bone marrow transplantation 1991;7(5):389-92.
-
1991: Conlan M G; Haire W D; Lieberman R P; Lund G; Kessinger A; Armitage J O
Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation.
Bone marrow transplantation 1991;7(3):235-40.
-
1991: Vose J M; Bierman P J; Kessinger A; Coccia P F; Anderson J; Oldham F B; Epstein C; Armitage J O
The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
Bone marrow transplantation 1991;7(2):139-43.
-
1991: Haire W D; Lieberman R P; Lund G B; Edney J A; Kessinger A; Armitage J O
Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters.
Bone marrow transplantation 1991;7(1):57-9.
-
1990: Edney J A; Hofmann S; Thompson J S; Kessinger A
Glucagonoma syndrome is an underdiagnosed clinical entity.
American journal of surgery 1990;160(6):625-8; discussion 628-9.
-
1990: Haire W D; Lieberman R P; Edney J; Vaughan W P; Kessinger A; Armitage J O; Goldsmith J C
Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation.
Cancer 1990;66(5):900-8.
-
1990: Haire W D; Lieberman R P; Lund G B; Wieczorek B M; Armitage J O; Kessinger A
Translumbar inferior vena cava catheters: safety and efficacy in peripheral blood stem cell transplantation.
Transfusion 1990;30(6):511-5.
-
1990: Vose J M; Peterson C; Bierman P J; Weisenburger D D; Linder J; Harrington D; Vaughan W P; Kessinger A; Armitage J O
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.
Blood 1990;76(2):424-31.
-
1990: Kessinger A; Nademanee A; Forman S J; Armitage J O
Autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Hematology/oncology clinics of North America 1990;4(3):577-87.
-
1990: Lund G B; Lieberman R P; Haire W D; Martin V A; Kessinger A; Armitage J O
Translumbar inferior vena cava catheters for long-term venous access.
Radiology 1990;174(1):31-5.
-
1990: Kessinger A; Schmit-Pokorny K; Smith D; Armitage J
Cryopreservation and infusion of autologous peripheral blood stem cells.
Bone marrow transplantation 1990;5 Suppl 1():25-7.
-
1990: Haire W D; Lieberman R P; Lund G B; Wieczorek B M; Armitage J O; Kessinger A
Translumbar inferior vena cava catheters: experience with 58 catheters in peripheral stem cell collection and transplantation.
Transfusion science 1990;11(2):195-200.
-
1990: Schouten H C; Kessinger A; Smith D M; Landmark J D; Wigton R S; Weisenburger D D; Armitage J O
Counterflow centrifugation apheresis for the collection of autologous peripheral blood stem cells from patients with malignancies: a comparison with a standard centrifugation apheresis procedure.
Journal of clinical apheresis 1990;5(3):140-4.
-
1990: Haire W D; Edney J A; Landmark J D; Kessinger A
Thrombotic complications of subclavian apheresis catheters in cancer patients: prevention with heparin infusion.
Journal of clinical apheresis 1990;5(4):188-91.
-
1990: Smith D M; Ness M J; Landmark J D; Haire W W; Kessinger A
Recurrent neurologic symptoms during peripheral stem cell apheresis in two patients with intracranial metastases.
Journal of clinical apheresis 1990;5(2):70-3.
-
1990: Kessinger A
Autologous transplantation with peripheral blood stem cells: a review of clinical results.
Journal of clinical apheresis 1990;5(2):97-9.
-
1989: Robbins R A; Linder J; Stahl M G; Thompson A B; Haire W; Kessinger A; Armitage J O; Arneson M; Woods G; Vaughan W P
Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients.
The American journal of medicine 1989;87(5):511-8.
-
1989: Schouten H C; Bierman P J; Vaughan W P; Kessinger A; Vose J M; Weisenburger D D; Armitage J O
Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation.
Blood 1989;74(7):2579-84.
-
1989: Kessinger A; Smith D M; Strandjord S E; Landmark J D; Dooley D C; Law P; Coccia P F; Warkentin P I; Weisenburger D D; Armitage J O
Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.
Bone marrow transplantation 1989;4(6):643-6.
-
1989: Kessinger A; Armitage J O; Smith D M; Landmark J D; Bierman P J; Weisenburger D D
High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma.
Blood 1989;74(4):1260-5.
-
1989: Schouten H C; Armitage J O; Klassen L W; Vaughan W P; Bierman P J; Weisenburger D; Kessinger A
Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.
Bone marrow transplantation 1989;4(1):119-21.
-
1988: Kessinger A; Armitage J O; Landmark J D; Smith D M; Weisenburger D D
Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy.
Blood 1988;71(3):723-7.
-
1988: Glenn L D; Sanger W G; Kessinger A; Vaughan W P
Failure of karyotypic instability to predict clinical progression in patients with dysmyelopoietic syndromes.
Hematologic pathology 1988;2(4):239-48.
-
1987: Kessinger A; Armitage J O; Klassen L W; Landmark J D; Hayes J M; Larsen A E; Purtilo D T
Graft versus host disease following transfusion of normal blood products to patients with malignancies.
Journal of surgical oncology 1987;36(3):206-9.
-
1987: Kessinger A; Wigton R S
Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study.
Journal of surgical oncology 1987;36(2):81-3.
-
1987: Smith D M; Weisenburger D D; Bierman P; Kessinger A; Vaughan W P; Armitage J O
Acute renal failure associated with autologous bone marrow transplantation.
Bone marrow transplantation 1987;2(2):195-201.
-
1987: Kessinger A; Armitage J O
Harvesting marrow for autologous transplantation from patients with malignancies.
Bone marrow transplantation 1987;2(1):15-8.
-
1987: Joshi S S; Kessinger A; Mann S L; Stevenson M; Weisenburger D D; Vaughan W P; Armitage J O; Sharp J G
Detection of malignant cells in histologically normal bone marrow using culture techniques.
Bone marrow transplantation 1987;1(3):303-10.
Sign-in to see more